Insider Transactions in Q1 2023 at Puma Biotechnology, Inc. (PBYI)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 10
2023
|
Alvin F Wong Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,601
+34.12%
|
-
|
Feb 10
2023
|
Douglas M Hunt Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,136
+28.72%
|
-
|
Feb 10
2023
|
Maximo F Nougues Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,601
+26.93%
|
-
|
Feb 10
2023
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,972
+34.88%
|
-
|
Feb 10
2023
|
Alan H Auerbach President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
186,403
+2.58%
|
-
|
Jan 03
2023
|
Maximo F Nougues Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,499
-9.46%
|
$41,996
$4.18 P/Share
|
Jan 03
2023
|
Alvin F Wong Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,460
-5.96%
|
$13,840
$4.18 P/Share
|
Jan 03
2023
|
Alan H Auerbach President and CEO |
SELL
Open market or private sale
|
Direct |
27,241
-0.4%
|
$108,964
$4.18 P/Share
|
Jan 03
2023
|
Douglas M Hunt Officer |
SELL
Open market or private sale
|
Direct |
4,225
-5.59%
|
$16,900
$4.18 P/Share
|
Jan 03
2023
|
Jeffrey Jerome Ludwig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,568
-10.16%
|
$26,272
$4.18 P/Share
|